Assessing subvisible particle risks in monoclonal antibodies: insights from quartz crystal microbalance with dissipation, machine learning, and in silico analysis

Throughout the lifecycle of biopharmaceutical development and manufacturing, monoclonal antibodies (mAbs) are subjected to diverse interfacial stresses and encounter various container surfaces. These interactions can cause the formation of subvisible particles (SVPs) that complicate developability a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yibo Wang, Alexis Hanford, Mehdi Boroumand, Cavan Kalonia, Jesse Leissa, Mitali Shah, Tony Pham, Theodore Randolph, Indira Prajapati
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2025.2501629
Tags: Add Tag
No Tags, Be the first to tag this record!